- Report
- August 2024
- 189 Pages
Global
From €3790EUR$4,000USD£3,199GBP
- Report
- December 2024
- 100 Pages
Global
From €5638EUR$5,950USD£4,758GBP
- Report
- January 2025
- 185 Pages
Global
From €4264EUR$4,500USD£3,599GBP
- Report
- September 2023
- 182 Pages
Global
From €3790EUR$4,000USD£3,199GBP
- Report
- October 2021
- 139 Pages
Global
From €3790EUR$4,000USD£3,199GBP
Biomarkers are biological molecules that can be used to measure and monitor the progression of a disease. Disease markers are a type of biomarker that can be used to diagnose, monitor, and predict the progression of a disease. Disease markers can be used to identify the presence of a disease, measure the severity of a disease, and predict the risk of developing a disease. Disease markers can be found in a variety of biological samples, including blood, urine, saliva, and tissue.
Disease markers are used in a variety of medical applications, including diagnostics, prognostics, and drug development. They can be used to identify the presence of a disease, measure the severity of a disease, and predict the risk of developing a disease. Disease markers can also be used to monitor the effectiveness of treatments and to identify potential drug targets.
The disease marker market is a rapidly growing sector of the biomarker market. Companies in this market are focused on developing and commercializing disease markers for a variety of medical applications. Examples of companies in this market include Bio-Rad Laboratories, Illumina, Qiagen, and Thermo Fisher Scientific. Show Less Read more